Development of a Biomarker Panel to Distinguish Risk of Progressive Chronic Kidney Disease

Development of a Biomarker Panel to Distinguish Risk of Progressive Chronic Kidney Disease

Chronic kidney disease (CKD) patients typically progress to kidney failure, but the rate of progression differs per patient or may not occur at all. Current CKD screening methods are sub-optimal at predicting progressive kidney function decline. This investigation develops a model for predicting pro...

Full description

Bibliographic Details
Main Authors: Evan Owens, Ken-Soon Tan, Robert Ellis, Sharon Del Vecchio, Tyrone Humphries, Erica Lennan, David Vesey, Helen Healy, Wendy Hoy, Glenda Gobe
Format: Article
Language:English
Published: MDPI AG 2020-12-01
Series:Biomedicines
Subjects:
chronic kidney disease
progression
biomarkers
progressive
Online Access:https://www.mdpi.com/2227-9059/8/12/606

Internet

https://www.mdpi.com/2227-9059/8/12/606

Similar Items